Overview
Sotera Health provides sterilization and lab testing services for the healthcare industry. It operates three units: Sterigenics, which handles outsourced terminal sterilization and irradiation (Gamma, EtO, Ebeam, X-ray) across facilities in multiple countries; Nordion, which supplies long-term Cobalt-60 sources for irradiation; and Nelson Labs, which offers outsourced microbiological and analytical testing across many labs with hundreds of tests. Revenue comes from sterilization services, testing, and advisory services for medical devices, pharmaceuticals, and food safety. Its goal is to be a reliable, mission-critical partner by delivering an integrated portfolio, global reach, and trusted testing and sterilization to ensure product safety and quality.
Work here?Claim your company
Simplify's take
What believers are saying
- Q2 2026 revenue rose 9.2% to $321 million; guidance increased August 6, 2026.
- Sterigenics grew 8.6%; Nordion grew 15.8%; Nelson Labs grew 6.3% in Q2.
- Net leverage hit three times, and 2027 capex should fall after 2026 upgrades.
What critics are saying
- Georgia appellate rulings in 2026 still threaten roughly 450 EtO lawsuits.
- California trials are expected January or April 2027, keeping liability headlines alive.
- A large adverse judgment or injunction could cripple Sterigenics and force divestiture.
What makes Sotera Health unique
- Sterigenics, Nordion, and Nelson Labs serve regulated healthcare workflows end-to-end.
- EO, gamma, X-ray, and Cobalt-60 capabilities create switching costs across customers.
- Forty-eight facilities in 13 countries and 15 labs provide global redundancy and reach.
Help us improve and share your feedback! Did you find this helpful?